Concepts (236)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- 2-Naphthylamine
- Adenine
- Adenosine Monophosphate
- Adolescent
- Adult
- Africa South of the Sahara
- Africa, Western
- Age Factors
- Aged
- Aged, 80 and over
- AIDS-Related Opportunistic Infections
- Alanine
- Alanine Transaminase
- Ambulatory Care Facilities
- Analgesics, Opioid
- Anilides
- Animals
- Antibodies, Monoclonal, Humanized
- Antibodies, Neutralizing
- Antibodies, Viral
- Antigens, CD20
- Anti-HIV Agents
- Antineoplastic Combined Chemotherapy Protocols
- Anti-Retroviral Agents
- Antiretroviral Therapy, Highly Active
- Antiviral Agents
- Aspartate Aminotransferases
- Asymptomatic Infections
- Benzimidazoles
- Betacoronavirus
- Biomarkers
- Biomedical Research
- Biopsy
- Biosensing Techniques
- Blood Chemical Analysis
- Blood Component Transfusion
- Blood Safety
- Blood Specimen Collection
- Blood Transfusion
- B-Lymphocytes
- Bullying
- Cameroon
- Carbamates
- Carcinoma, Hepatocellular
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes
- Chlamydia Infections
- Chlamydia trachomatis
- Chloroquine
- Clinical Deterioration
- Clinical Laboratory Techniques
- Clinical Trials, Phase II as Topic
- Codon
- Coffee
- Cohort Studies
- Coinfection
- Combined Modality Therapy
- Comorbidity
- Continuity of Patient Care
- Coronavirus Infections
- Cost of Illness
- Cote d'Ivoire
- Cross-Sectional Studies
- Cyclopropanes
- Cytokines
- Delivery of Health Care
- Dendritic Cells
- Diagnostic Tests, Routine
- Disease Eradication
- Disease Progression
- DNA, Viral
- Double-Blind Method
- Dried Blood Spot Testing
- Drug Administration Schedule
- Drug Combinations
- Drug Resistance, Neoplasm
- Drug Resistance, Viral
- Drug Therapy, Combination
- Drug Users
- Drug Utilization
- Drug-Related Side Effects and Adverse Reactions
- Elasticity Imaging Techniques
- Esophageal and Gastric Varices
- Europe
- Female
- Fibrosis
- Fluorenes
- Follow-Up Studies
- France
- Gastrointestinal Hemorrhage
- Gene Expression Profiling
- Genotype
- Global Health
- Guanine
- Health Resources
- Health Services Accessibility
- Hematologic Neoplasms
- Hemoglobinuria, Paroxysmal
- Hepacivirus
- Hepatic Encephalopathy
- Hepatitis B
- Hepatitis B Antibodies
- Hepatitis B Core Antigens
- Hepatitis B e Antigens
- Hepatitis B Surface Antigens
- Hepatitis B Vaccines
- Hepatitis B virus
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C Antibodies
- Hepatitis C Antigens
- Hepatitis C, Chronic
- Hepatitis D
- Hepatitis Delta Virus
- Hepatitis, Viral, Human
- Hepatorenal Syndrome
- HIV
- HIV Infections
| - HIV Protease Inhibitors
- HIV-1
- Humans
- Hydroxychloroquine
- Imidazoles
- Immune Sera
- Immunization, Passive
- Immunoglobulin G
- Immunologic Tests
- Immunotherapy
- Incidence
- Inflammation
- Injections
- Interferon beta-1a
- Interferon Type I
- Interferon-alpha
- Interleukin-6
- Kinetics
- Lab-On-A-Chip Devices
- Lactams, Macrocyclic
- Lamivudine
- Length of Stay
- Leukocytes, Mononuclear
- Liver
- Liver Cirrhosis
- Liver Neoplasms
- Liver Transplantation
- Logistic Models
- Lopinavir
- Lymphocyte Count
- Lymphocytes
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphopenia
- Macrocyclic Compounds
- Macrophage Activation
- Male
- Mass Screening
- Medication Adherence
- Metabolic Syndrome
- Microfluidics
- Middle Aged
- Morbidity
- Mutation
- Mutation Rate
- Nanotechnology
- Neoplasms
- Obesity
- Opiate Substitution Treatment
- Organophosphonates
- Oxygen Inhalation Therapy
- Pandemics
- Paris
- Patient Reported Outcome Measures
- Pharmaceutical Preparations
- Pilot Projects
- Plasma
- Platelet Count
- Pneumonia, Viral
- Point-of-Care Systems
- Point-of-Care Testing
- Polyethylene Glycols
- Poverty
- Practice Guidelines as Topic
- Prevalence
- Proline
- Promoter Regions, Genetic
- Proportional Hazards Models
- Prospective Studies
- Protein Precursors
- Pyrrolidines
- Qualitative Research
- Quinoxalines
- Randomized Controlled Trials as Topic
- Recombinant Proteins
- Reproducibility of Results
- Retrospective Studies
- Ribavirin
- Risk Assessment
- Risk Factors
- Ritonavir
- Rituximab
- RNA
- RNA, Viral
- ROC Curve
- Secondary Prevention
- Sensitivity and Specificity
- Seroconversion
- Seroepidemiologic Studies
- Serologic Tests
- Severity of Illness Index
- Sex Factors
- Sexual Behavior
- Sexual Partners
- Sexually Transmitted Diseases
- Sofosbuvir
- Spike Glycoprotein, Coronavirus
- Substance Abuse, Intravenous
- Sulfonamides
- Survival Analysis
- Sustained Virologic Response
- Swine
- Synthetic Biology
- Teas, Herbal
- Tenofovir
- Time Factors
- Treatment Outcome
- Uracil
- Urinalysis
- Vaccination
- Valine
- Vietnam
- Viral Core Proteins
- Viral Load
- Viremia
- Virus Replication
- World Health Organization
- Young Adult
|
Lacombe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(227)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_